Pathway,Score
Signaling by VEGF,0.045615404557515817
Negative regulation of the PI3K/AKT network,0.027369279087648305
PI3K/AKT Signaling in Cancer,0.0176672889617446
G beta:gamma signalling through PI3Kgamma,0.07396571890025558
G-protein beta:gamma signalling,-0.01814760162260596
VEGFA-VEGFR2 Pathway,0.01758230987500576
VEGFR2 mediated vascular permeability,0.01637789010641465
Constitutive Signaling by AKT1 E17K in Cancer,0.0567947379444726
Respiratory Syncytial Virus Infection Pathway,0.04755626925569945
RSV-host interactions,0.04212042283735037
RHO GTPases Activate WASPs and WAVEs,-0.0022473177218729034
RAC2 GTPase cycle,0.033158972534094874
RAC3 GTPase cycle,-0.08939283511188308
Parasite infection,0.06965156792745324
Leishmania phagocytosis,0.009303083282377497
FCGR3A-mediated phagocytosis,0.037482570970183364
Signaling by NOTCH1,0.02195024775563211
NOTCH1 Intracellular Domain Regulates Transcription,-0.012119717401564811
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.008760665052099768
Signaling by NOTCH1 in Cancer,0.00758350228725205
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.02617826331836363
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.050997955206185525
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.004595549334747653
Regulation of PTEN gene transcription,0.018824077724147566
Budding and maturation of HIV virion,0.029997125186160968
Uptake and actions of bacterial toxins,0.013730727562601488
Bacterial Infection Pathways,-0.04866254878385038
NRAGE signals death through JNK,0.0060668447452529115
p75 NTR receptor-mediated signalling,-0.024995233776085344
"Cell death signalling via NRAGE, NRIF and NADE",0.014921125745120481
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.0020241645086007103
Neurodegenerative Diseases,0.03473265183491289
Diseases of programmed cell death,0.037793102429437384
Defective Intrinsic Pathway for Apoptosis,0.004865808899918351
Signaling by SCF-KIT,-0.023036064554874745
Regulation of KIT signaling,0.00676006552963558
Degradation of beta-catenin by the destruction complex,0.008261595052130795
Beta-catenin phosphorylation cascade,0.004919120261219625
Disassembly of the destruction complex and recruitment of AXIN to the membrane,0.0015348698211494012
G alpha (12/13) signalling events,0.03313854967268708
Pre-NOTCH Transcription and Translation,-0.06125484337162201
Pre-NOTCH Expression and Processing,-0.02183983061489288
Signaling by NOTCH2,-0.052939520456589784
NOTCH2 intracellular domain regulates transcription,-0.01769172516184539
Signaling by NOTCH3,0.007708764051437662
NOTCH3 Intracellular Domain Regulates Transcription,-0.016308550077924346
Signaling by NOTCH4,-0.011244948620435645
NOTCH4 Intracellular Domain Regulates Transcription,0.004318401765263523
Signaling by MET,0.019593151118696275
RAS processing,0.019144434270409044
Potential therapeutics for SARS,-0.06477728322081015
Host Interactions of HIV factors,-0.08383656631837798
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.024197307094272973
The role of Nef in HIV-1 replication and disease pathogenesis,0.005976179372308162
NR1H2 and NR1H3-mediated signaling,0.027760611932332972
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.02382105297385805
Diseases of glycosylation,0.051813185738609054
Diseases associated with O-glycosylation of proteins,0.011202945690560129
Defective GALNT3 causes HFTC,-0.007677985658292014
Defective GALNT12 causes CRCS1,0.0035579408191880393
Diseases of metabolism,0.0348022028584574
Diseases of DNA repair,0.03025114107699108
Diseases of DNA Double-Strand Break Repair,-0.010474372771295025
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.011871811558826592
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,0.0014790405332930872
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.004188883870655778
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,-0.004011627730487204
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.006431893602909046
Impaired BRCA2 binding to RAD51,0.007737985759304612
Impaired BRCA2 binding to PALB2,0.037096852082667185
Effects of PIP2 hydrolysis,-0.07892104305964003
Integrin signaling,-0.006646502480119858
Retrograde neurotrophin signalling,-0.004897314567931753
Signaling by NTRK1 (TRKA),-0.12837243567305723
TNFR1-induced proapoptotic signaling,-0.0022077035882364132
Regulation of TNFR1 signaling,-0.047596437088392084
TNFR1-induced NF-kappa-B signaling pathway,0.056324578823843584
TNF signaling,0.022668105904200386
RHOA GTPase cycle,0.06831821581319143
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.00651118102059434
HCMV Infection,-0.01439193011548367
HCMV Early Events,0.007727804247483277
Regulation of RAS by GAPs,-0.12169721369451052
RHOF GTPase cycle,-0.017253410514707863
P2Y receptors,0.0018263508497075674
Nucleotide-like (purinergic) receptors,0.009327287929530295
Signaling by PTK6,-0.07215036868116216
Signaling by Non-Receptor Tyrosine Kinases,0.021051026447720663
Signaling by Retinoic Acid,-0.009903808310026697
RA biosynthesis pathway,-0.022809236485900254
Signaling by ERBB2,-0.015470548442674453
Downregulation of ERBB2 signaling,0.00956528512378406
Activated NOTCH1 Transmits Signal to the Nucleus,0.0019438106773279032
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.015372213582662789
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.03909626315228207
Opioid Signalling,-0.04708843135856219
DARPP-32 events,0.036692556321891154
Nuclear Events (kinase and transcription factor activation),-0.006426179799452884
Signaling by NTRK2 (TRKB),-0.0014545208830772046
NGF-stimulated transcription,0.0045554496960310414
Class B/2 (Secretin family receptors),0.033892322380637434
G alpha (s) signalling events,-0.059781774847834146
RHOB GTPase cycle,-0.018213921557024476
RHOC GTPase cycle,-0.015197712668551074
Vpu mediated degradation of CD4,0.0012007946538391343
Vif-mediated degradation of APOBEC3G,-0.04947725116239555
PCP/CE pathway,-0.0558873560525559
Asymmetric localization of PCP proteins,0.034272108729766056
Degradation of AXIN,0.028828080790040896
Degradation of DVL,0.0019802366271630093
Hedgehog ligand biogenesis,-0.031050725144045298
Hh mutants are degraded by ERAD,0.007781829914576497
Hh mutants abrogate ligand secretion,0.004425388324020976
Degradation of GLI1 by the proteasome,-0.0028336827499150373
Degradation of GLI2 by the proteasome,-0.11610868410923357
GLI3 is processed to GLI3R by the proteasome,-0.00900657049423067
Hedgehog 'off' state,-0.012525447564529921
ABC transporter disorders,-0.032012749658251155
Disorders of transmembrane transporters,0.02168129097610469
Hedgehog 'on' state,0.026145668145762392
Defective CFTR causes cystic fibrosis,0.016306142418949444
MAPK6/MAPK4 signaling,0.011135398281318478
Regulation of PTEN stability and activity,-0.009834309184834448
Negative regulation of NOTCH4 signaling,-0.005204430404703418
Formation of HIV elongation complex in the absence of HIV Tat,-0.034539916346574336
Formation of the HIV-1 Early Elongation Complex,0.0008881337956609319
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.026791806039383383
HIV Transcription Initiation,0.0014744446614403583
RNA Polymerase II HIV Promoter Escape,-0.008618791139707621
HIV Transcription Elongation,-0.008770477814755486
Transcription of the HIV genome,0.018995583430803643
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.005856077953884634
Tat-mediated elongation of the HIV-1 transcript,-0.017334128240923067
RHOBTB3 ATPase cycle,0.003691953691404654
Signaling by TGF-beta Receptor Complex,0.0317595293512348
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.0897219594976683
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.03855882258339117
Pausing and recovery of Tat-mediated HIV elongation,0.02000626868594686
Tat-mediated HIV elongation arrest and recovery,-0.04342060635756751
HIV elongation arrest and recovery,0.006712133780093257
Pausing and recovery of HIV elongation,0.00358925714775033
Estrogen-dependent gene expression,0.009333315794356629
RHOBTB2 GTPase cycle,0.031823603639467346
RHOBTB1 GTPase cycle,0.020460604517897753
RHOBTB GTPase Cycle,-0.06149375825755406
Signaling by EGFR,0.009095783207496612
EGFR downregulation,-0.0037581940297479882
Signaling by FGFR,0.08766230438273927
Negative regulation of FGFR1 signaling,0.014123900903753218
Negative regulation of FGFR2 signaling,0.010992393552997755
Negative regulation of FGFR3 signaling,-0.0008200292549463958
Negative regulation of FGFR4 signaling,0.024377472455371023
Signaling by FGFR1,0.013570975020355763
Signaling by FGFR2,0.009366501371963869
Signaling by FGFR3,-0.027399410733322173
Signaling by FGFR4,0.009038520780411247
Negative regulation of MET activity,-0.010583537024907769
InlB-mediated entry of Listeria monocytogenes into host cell,0.015472065826212402
Listeria monocytogenes entry into host cells,0.014650285201687896
RHOU GTPase cycle,0.0023797164439300134
MAP2K and MAPK activation,-0.0009260807270751331
Signaling by moderate kinase activity BRAF mutants,0.04141459342781698
Signaling by high-kinase activity BRAF mutants,0.021079258114365847
Signaling by RAS mutants,-0.0033705078108749367
Signaling by BRAF and RAF1 fusions,-0.0007605112473881533
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.0023637712143536323
Oncogenic MAPK signaling,-0.024946888292818225
Signaling downstream of RAS mutants,0.014430873686779146
Signaling by RAF1 mutants,0.032889265672854835
AKT phosphorylates targets in the cytosol,-0.0008582663598876309
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.005557862527417084
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.030969780083347356
Diseases of mitotic cell cycle,-0.002401442913240227
FLT3 signaling in disease,-0.017136799711291957
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.008458767457792324
Signaling by ALK in cancer,-0.14802882123904224
Signaling by FLT3 ITD and TKD mutants,-0.010038912739633659
Signaling by ALK fusions and activated point mutants,-0.02131539763555971
RHO GTPases activate CIT,0.056748294817776365
Extra-nuclear estrogen signaling,0.01367960276545699
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.005875074401751895
Signaling by Activin,0.0014770395060966783
Downregulation of TGF-beta receptor signaling,-0.023894876092225032
TGF-beta receptor signaling activates SMADs,0.01816844484310557
G alpha (z) signalling events,-0.01287436436702977
Activation of RAC1,0.000827955199851728
RHOQ GTPase cycle,-0.021903675377683538
RHOH GTPase cycle,-0.009971622697266444
RHOG GTPase cycle,-0.03663446882431001
RHOJ GTPase cycle,0.047032632519823724
RHOV GTPase cycle,0.02346094069966012
Signaling by Insulin receptor,0.04824630115610055
Insulin receptor recycling,0.02088136801755838
MET activates PTK2 signaling,0.00694635099980278
MET promotes cell motility,-0.016166945470685923
MTOR signalling,-0.006633957978890629
mTORC1-mediated signalling,0.00364930127815816
Energy dependent regulation of mTOR by LKB1-AMPK,-0.0020052155745991502
Diseases of Immune System,0.005823592178171529
Diseases associated with the TLR signaling cascade,-0.037398190849518446
RHO GTPases activate IQGAPs,-0.01896924375151537
RHO GTPases Activate Formins,0.04387553285650685
RHO GTPases activate PKNs,-0.011842149506369772
RHO GTPases Activate ROCKs,-0.02092626402716225
RHO GTPases activate PAKs,-0.0332930659570169
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.013355776408562647
Pre-NOTCH Processing in Golgi,0.006401708212206315
Signaling by ERBB4,-0.0032847275727450847
Nuclear signaling by ERBB4,0.02413446114921531
Signaling by Hippo,0.056927540626924275
RHOD GTPase cycle,-0.02145174681251812
SARS-CoV-1-host interactions,-0.11463917165009745
SARS-CoV-1 activates/modulates innate immune responses,-0.04661197351030827
RND3 GTPase cycle,0.025826893672942153
Nuclear events stimulated by ALK signaling in cancer,-0.005087592073177696
HCMV Late Events,-0.01570118386767584
Formation of the beta-catenin:TCF transactivating complex,0.011033264625027753
Peptide ligand-binding receptors,-0.028222597639041055
Chemokine receptors bind chemokines,0.001692564113700036
Translation of Structural Proteins,0.02133347013088233
Maturation of spike protein,0.0074609959579498035
Late SARS-CoV-2 Infection Events,-0.05390493303907218
Purinergic signaling in leishmaniasis infection,-0.015654524586117255
Cell recruitment (pro-inflammatory response),0.013407403690687223
CaMK IV-mediated phosphorylation of CREB,-0.01918500157674487
Calmodulin induced events,-0.03718536150066596
Ca-dependent events,0.0099225618685659
CaM pathway,-0.011977583688686164
G-protein mediated events,0.024924884396372925
PLC beta mediated events,-0.027038259759498848
DAG and IP3 signaling,0.006660757471208222
G-protein activation,0.005224353054988369
Ca2+ pathway,-0.1278098618163692
G beta:gamma signalling through PLC beta,-0.001997818781243339
Glucagon-type ligand receptors,0.020447901321607582
G beta:gamma signalling through BTK,-0.012905822374632416
G beta:gamma signalling through CDC42,-0.03375979444500555
GPER1 signaling,0.012069093134321161
ADORA2B mediated anti-inflammatory cytokines production,0.009019199363216598
Anti-inflammatory response favouring Leishmania parasite infection,0.012945706434345177
Leishmania parasite growth and survival,-0.007361762976677121
PKA-mediated phosphorylation of CREB,-0.07963134600091125
PKA activation,0.023655129421726196
Adenylate cyclase activating pathway,0.0005983384500528841
Adenylate cyclase inhibitory pathway,-0.006513110378458175
FCGR3A-mediated IL10 synthesis,-0.0002454905869970621
Signaling by ERBB2 in Cancer,0.0064082921287440635
Constitutive Signaling by Aberrant PI3K in Cancer,0.000971996563102473
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.17073545218403188
Signaling by ERBB2 KD Mutants,-0.00532262182829389
Signaling by ERBB2 TMD/JMD mutants,0.004972734982446918
RND2 GTPase cycle,0.019026860008220025
Signaling by TGFBR3,0.07017390899375972
Rev-mediated nuclear export of HIV RNA,-0.0032011171399291497
Transport of Ribonucleoproteins into the Host Nucleus,0.019173748178398453
Export of Viral Ribonucleoproteins from Nucleus,-0.023327829476732453
NS1 Mediated Effects on Host Pathways,-0.009514673540604292
Viral Messenger RNA Synthesis,0.017331090342638845
NEP/NS2 Interacts with the Cellular Export Machinery,0.018163595558523985
Interactions of Vpr with host cellular proteins,0.02521374021161613
Interactions of Rev with host cellular proteins,0.0020906271709612346
Nuclear import of Rev protein,-0.033988616396838686
Vpr-mediated nuclear import of PICs,0.018375353179736858
SLC transporter disorders,-0.026585163157286634
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.021020109613396235
VEGFR2 mediated cell proliferation,-0.003690923416914028
Eicosanoid ligand-binding receptors,-0.057296761542529814
RHO GTPases Activate NADPH Oxidases,0.013117620282414375
Downstream signaling of activated FGFR1,-0.004695093936422117
FRS-mediated FGFR1 signaling,-0.01933694996005976
Downstream signaling of activated FGFR2,0.03716405056378225
FRS-mediated FGFR2 signaling,0.008785612365032136
FRS-mediated FGFR3 signaling,0.008171776362774476
Downstream signaling of activated FGFR3,-0.09523531913921986
FRS-mediated FGFR4 signaling,0.014280162957401685
Downstream signaling of activated FGFR4,-0.01906332593667888
RND1 GTPase cycle,-0.027711634370824332
Signaling by FGFR in disease,0.009865690694028983
Prolonged ERK activation events,0.00043471377402513574
Frs2-mediated activation,-0.005712919625588205
Signalling to ERKs,-0.1918746930204058
Signaling by ALK,-0.021327339439908454
Signaling by FGFR2 in disease,-0.07867461694840089
Signaling by FGFR1 in disease,-0.04834118229708877
Signaling by FGFR3 in disease,0.0075257989109518775
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.0025004609639332535
Activation of SMO,-0.002465110940560815
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.009838370557761529
Signaling by EGFR in Cancer,0.023880933025361387
Constitutive Signaling by EGFRvIII,-0.0033343440567159574
Signaling by EGFRvIII in Cancer,0.007270805370256862
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.02288299066316283
Signaling by ERBB2 ECD mutants,0.01951716412152453
Infection with Mycobacterium tuberculosis,0.0007767879838466781
Response of Mtb to phagocytosis,-0.016931018723816277
Signaling by BMP,-0.01554803494640945
Early Phase of HIV Life Cycle,-0.0066139051473194065
SARS-CoV-2 modulates host translation machinery,-0.002956469941409134
RAF-independent MAPK1/3 activation,-0.00698848916485657
Negative regulation of MAPK pathway,0.0015087462764057265
Viral mRNA Translation,-0.03620229991790822
Amine ligand-binding receptors,-0.007868363094215678
Neurotoxicity of clostridium toxins,0.009263814022498457
SARS-CoV-2 modulates autophagy,-0.002661189708350904
PI3K Cascade,-0.017457675843598874
IRS-mediated signalling,-0.04626656299168639
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.030319555741018137
IGF1R signaling cascade,-0.05259175135792346
IRS-related events triggered by IGF1R,-0.0011197648541470895
Insulin receptor signalling cascade,0.0005510954383621664
WNT5A-dependent internalization of FZD4,0.011513690565219484
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.06300075687007373
Induction of Cell-Cell Fusion,-0.023270638262268814
Signaling by PDGF,0.0002861214454760734
Translation of Replicase and Assembly of the Replication Transcription Complex,0.017021395837481915
Early SARS-CoV-2 Infection Events,0.05516048039802494
Assembly Of The HIV Virion,-0.04201432512748522
Evasion by RSV of host interferon responses,0.019399292770585892
Downstream signal transduction,0.011284184112694365
p130Cas linkage to MAPK signaling for integrins,-0.04024124329035155
Signaling by Erythropoietin,0.03369158225547062
SARS-CoV-1 modulates host translation machinery,0.01517048323439795
Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.007282732288857419
Maturation of nucleoprotein,0.004232080543288253
Signalling to RAS,0.031124581572947587
FGFR2 ligand binding and activation,-0.00035967476528328963
Signaling by WNT in cancer,-0.01974380302750538
Signaling by AXIN mutants,0.04722791835979348
Signaling by CTNNB1 phospho-site mutants,-0.0016813198155497578
Signaling by APC mutants,0.0052457061406747
Signaling by AMER1 mutants,0.009166081018817685
Signaling by GSK3beta mutants,0.00603437307705203
CTNNB1 S33 mutants aren't phosphorylated,-0.01600317462294119
CTNNB1 S37 mutants aren't phosphorylated,0.03131020623334093
CTNNB1 S45 mutants aren't phosphorylated,-0.0017202687296675543
CTNNB1 T41 mutants aren't phosphorylated,0.0017328801989975617
APC truncation mutants have impaired AXIN binding,-0.040238422439329784
AXIN missense mutants destabilize the destruction complex,-0.00569745657920908
Truncations of AMER1 destabilize the destruction complex,-0.003562890248585311
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.009199045021165066
Maturation of hRSV A proteins,-0.004078138805824586
RHO GTPases activate KTN1,-0.003719508990774466
Deactivation of the beta-catenin transactivating complex,0.019913768206883495
Repression of WNT target genes,0.012788547212477628
FGFR4 ligand binding and activation,-0.0072224674991751316
Phospholipase C-mediated cascade; FGFR4,0.031390270135011514
SHC-mediated cascade:FGFR4,0.04408047814907827
PI-3K cascade:FGFR4,0.06940066938782273
STAT3 nuclear events downstream of ALK signaling,0.0054253301729475225
Defective pyroptosis,-0.05653177470941745
ERK/MAPK targets,-0.011277617828543484
ERKs are inactivated,0.04634243635609847
TGFBR3 expression,-0.0026467554643450396
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.018377916196971433
Class C/3 (Metabotropic glutamate/pheromone receptors),0.051989425370289645
FGFR1 mutant receptor activation,-0.006945985599598261
FGFR2 mutant receptor activation,0.00940693543117768
Activated point mutants of FGFR2,0.034256918560277815
Phospholipase C-mediated cascade; FGFR2,-0.003790046586094598
PI-3K cascade:FGFR1,-0.004150222643731454
PI-3K cascade:FGFR2,-0.00841686364524023
SHC-mediated cascade:FGFR2,0.004834924198075771
Signaling by FGFR2 IIIa TM,-0.009959258733369112
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.03961402302337306
Abortive elongation of HIV-1 transcript in the absence of Tat,0.015965903106702182
FGFR2 alternative splicing,0.00583105329107129
Regulation of PTEN mRNA translation,0.029179734654649615
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.015880476169580524
NRIF signals cell death from the nucleus,-0.000199662495583779
Signaling by KIT in disease,-0.02967965334394317
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.015128894348374538
Loss of function of MECP2 in Rett syndrome,-0.01075888029277536
Pervasive developmental disorders,-0.0017349911759787192
Disorders of Developmental Biology,0.0217722694062687
Disorders of Nervous System Development,0.011490809131255789
Defects in vitamin and cofactor metabolism,0.0073796715338228
Regulation of FZD by ubiquitination,0.0047621866926267275
Serotonin receptors,0.010960021065525741
p75NTR signals via NF-kB,0.059647176055651605
Signaling by NTRK3 (TRKC),-0.00441363002616304
RAF activation,-0.006972910558060867
p75NTR regulates axonogenesis,0.0025936272576538772
WNT ligand biogenesis and trafficking,-0.00439405956387767
